During the past decade, CH GAP conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH GAP" #1 sponsor was "UNICANCER" with 3 trials, followed by "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "Rennes University Hospital" with 2 trials sponsored, "University Hospital, Brest" with 2 trials sponsored and "AB Science" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH GAP" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Fabre Clinic" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator, "French Lung Cancer Group" with 1 trials as a collaborator and "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CH GAP" are "Prostate Cancer" (2 trials), "Adenocarcinoma of Lung Metastatic to Brain" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Atrial Fibrillation" (1 trials) and "Bone Metastases" (1 trials). Many other conditions were trialed in "CH GAP" in a lesser frequency.

Most popular intervention types in "CH GAP" are "Drug" (13 trials), "Radiation" (4 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (3 trials), "Vinorelbine" (2 trials), "Anastrozole" (1 trials), "Bevacizumab" (1 trials) and "Cerebral Radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH GAP" are 14 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "CH GAP". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in CH GAP, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CH GAP, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

CH GAP has several departments that took part in Clinical trials: "Service de Pneumologie" - 3 trials